ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
How to invest
The top 3 qualities I look for when picking an ASX stock
Blue Chip Shares
3 no-brainer ASX 200 shares to buy after the market selloff
How to invest
The power of compounding: What your ASX share portfolio could become by 2040
How to invest
Understanding volatility: 'in the short run, the market is a voting machine but in the long run it is a weighing machine' – Ben Graham
How to invest
Don't waste this market selloff: Why now could be the time to buy ASX shares
Blue Chip Shares
3 ASX 200 shares for smart investors to buy and hold with $5,000
Share Market News
3 smart ASX shares to buy and hold for the next decade
Share Market News
5 reasons to buy these ASX shares after the market sell-off
How to invest
5 quality ASX shares for beginners to buy
Broker Notes
Top broker says these ASX 200 stocks are buys following the market selloff
How to invest
How long would it take to turn $10,000 into $1 million with ASX shares?
How to invest
How investing in ASX shares can transform your financial future
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
